Journal article
P.044 Salvage therapy in recurrent pediatric medulloblastoma: A single centre experience
Abstract
Background:
Children diagnosed with medulloblastoma (MB) that are refractory to upfront therapy or experience recurrence have very poor prognoses. Reports of phase I and II studies for these children exist, but bear significant treatment related morbidity and mortality.
Authors
Kameda-Smith M; Wang A; Adile A; Manoranjan B; Voth R; Sergeant A; Maharaj A; Ajani O; Yarascavitch B; Alyman C
Journal
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 45, No. s2, pp. s27–s27
Publisher
Cambridge University Press (CUP)
Publication Date
June 2018
DOI
10.1017/cjn.2018.146
ISSN
0317-1671